Craig B. Thompson

Insider Reports History

Entity
Individual
Location
2000 Galloping Hill Road, Kenilworth, New Jersey
Signature
/s/ Craig B. Thompson, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig B. Thompson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Director Common Stock 454 $432 K $951.26 Jan 2, 2024 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Common Stock 1,467 $335 K $228.41 May 13, 2024 Direct
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director Stock Options (Right to Buy) 1,311 $299 K $228.41 May 13, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 1,607 Jan 2, 2024 Direct

Insider Reports Filed by Craig B. Thompson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. May 13, 2024 2 427,127 4 May 15, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 2 0 4 Jan 4, 2024 Director
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. May 15, 2023 2 321,049 4 May 17, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2023 2 0 4 Jan 5, 2023 Director
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Jan 3, 2023 2 129,293 4 Jan 4, 2023 Director
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Dec 5, 2022 0 0 3 Dec 14, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Oct 3, 2022 2 0 4 Oct 5, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Oct 3, 2022 0 0 3 Oct 5, 2022 Director